Antimicrobial Resistance and Stewardship

Original Research Articles 

  1. Hostler CJ, Moehring RW, Ashley ESD, Johnson M, Davis A, Lewis SS, et al. Feasibility and Value of Developing a Regional Antibiogram for Community Hospitals. Infection Control & Hospital Epidemiology. Cambridge University Press; 2018;:1–5. DOI: 10.1017/ice.2018.71
  2. Manning ML, Septimus EJ, Ashley ES, Cosgrove SE, Fakih MG, Schweon SJ, Myers FE, Moody JA. Antimicrobial stewardship and infection prevention—leveraging the synergy: A position paper update. American Journal of Infection Control. 2018 Apr 1. DOI: 10.1016/j.ajic.2018.01.001
  3. Turner NA, Moehring RW, Sarubbi C, Wrenn RH, Drew RH, Cunningham CK, Fowler VG, Anderson DJ. "Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia". Open Forum Infectious Diseases. 2018 March 1 2018. DOI: 10.1093/ofid/ofy042.
  4. Moehring RW, Ashley ED, Ren X, Lokhnygina Y, Baker AW, Jones TM, Lewis SS, Sexton DJ, Anderson DJ. “Denominator Matters in Estimating Antimicrobial Use: A Comparison of Days Present and Patient Days.” Infection Control & Hospital Epidemiology, 2018 March 26. doi:10.1017/ice.2018.54.
  5. Hill, BK, Narayanan N, Palavecino E, Perez KK, Premraj S, Streifel, A, Wrenn RH, Zeitler K. The Role of an Antimicrobial Stewardship Team in the Use of Rapid Diagnostic Testing in Acute Care: An Official Position Statement of the Society of Infectious Diseases Pharmacists. Infection Control and Hospital Epidemiology 2018 Feb 13. DOI: 10.1017/ice.2018.11
  6. Fletcher JM, Kram SJ, Sarubbi CB, Anderson DJ, Kram BL.  Effectiveness of vancomycin or beta-lactam therapy in ampicillin-susceptible Enterococcus spp. bloodstream infection. J Pharm Pract 2018 epub ahead of print.  doi: 10.1177/0897190017751208
  7. Janda M, Acquisto NM, Gashlin LZ, Dodds Ashley E. Increasing the quality of medication histories in the emergency department with pharmacy students. Am J Emerg Med. 2017 Sep 28. pii: S0735-6757(17)30792-1. doi:10.1016/j.ajem.2017.09.047. [Epub ahead of print] PMID: 28974372
  8. Wrenn RH, Cluck D, Kennedy L, Ohl C, Williamson JC. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. J Oncol Pharm Pract. 2017 Jan 1:1078155216687151. doi: 10.1177/1078155216687151. [Epub ahead of print] PMID: 28077047
  9. Wrenn RH, Cluck D, Kennedy L, Ohl C, Williamson JC. Extended infusion compared to standard infusion cefepime as empiric treatment in febrile neutropenia. J Oncol Pharm Pract 2017 [Epub ahead of print] DOI: 10.1177/1078155216687151
  10. Jones TM, Drew RH, Wilson DT, Sarubbi C, Anderson DJ. (in press). Impact of automatic infectious diseases consultation on the management of fungemia at a large academic medical center. American Journal of Health-System Pharmacy DOI: 10.1093/ofid/ofw172.739
  11. Seidelman J, Dicks KV, Durkin MJ, Baker AW, Moehring RW, Anderson DJ, Sexton DJ, Chen LF, Lewis SS.  Using Clinical Scenarios to Understand Preventability of Clostridium difficile Infections by Inpatient Antibiotic Stewardship Programs.  Infect Control Hosp Epidemiol 2017 Mar 13:1-3. doi: 10.1017/ice.2017.32.
  12. Kanamori K, Parobek CM, Juliano JJ, Johnson JR, Johnston BD, Johnson TJ, Weber DJ, Rutala WA, Anderson DJ.  Genomic analysis of multidrug-resistant Escherichia coli from North Carolina community hospitals: ongoing circulation of CTX-M-producing ST131-H30Rx and ST131-H30R1 strains.  Antimicrob Agents Chemother 2017 Jun 5. pii: AAC.00912-17. doi: 10.1128/AAC.00912-17. [Epub ahead of print]
  13. Moehring RW, Anderson DJ, Cochran RL, Hicks LA, Srinivasan A, Ashley ED. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute care settings. Clinical Infectious Diseases. 2016 Dec 7. DOI: 10.1093/cid/ciw787
  14. Turner N, Anderson DJ, Cunnigham CK, Drew RH, Sarubbi C, Moehring RW. Impact of Reported Penicillin Allergy in Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases 2016 October 25. DOI: 10.1093/ofid/ofw172.1400
  15. Dicks KV, Anderson DJ, Baker AW, Sexton DJ, Lewis SS. Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals. Infect Control Hosp Epidemiol. 2017 Jan;38(1):31-38. doi:10.1017/ice.2016.230. Epub 2016 Oct 11. PubMed PMID: 27724988.
  16. Jacobi J, Ray S, Danelich I, Dodds Ashley E, Eckel S, Guharoy R, Militello M, O'Donnell P, Sam T, Crist SM, Smidt D. Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice. Pharmacotherapy. 2016 May;36(5):e40-9. doi: 10.1002/phar.1745. Epub 2016 Apr 27. PMID: 27118546
  17. Thaden JT, Fowler VG, Sexton DJ, Anderson DJ.  Increasing incidence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States.  Infect Control Hosp Epidemiol 2016;37(1):49-54. doi: 10.1017/ice.2015.239.
  18. Moehring RW, Hazen KC, Hawking MR, Drew RH, Sexton DJ, Anderson DJ.  Challenges in preparation of cumulative antibiogram reports for community hospitals.  J Clin Microbiol 2015;53(9):2977-82.  doi: 10.1128/JCM.01077-15
  19. Meredith HR, Lopatkin AJ, Anderson DJ, You L.  Bacterial temporal dynamics enable optimal design of antibiotic treatment.  PLoS Comput Biol 2015;11(4): e1004201. doi: 10.1371/journal.pcbi.1004201
  20. Garner B, Lokhnygina Y, Dodds-Ashley E, Johnson M, Drew RH, Davis A, Sexton DJ, Anderson D, Moehring RW.Harvesting the Low Hanging Fruit: A Benchmarking Tool for Implementation of Intravenous to Oral Antibiotic Switch Programs in 14 Southeastern Community Hospitals. Open Forum Infect Dis. 2015 Dec 9;2(Suppl 1):150. doi: 10.1093/ofid/ofv133.28. eCollection 2015 Dec. PMID: 27437415
  21. Payk SL, Drew RH, Smith JD, Jiroutek MR, Holland MA. Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists. Clin Ther. 2015 Jul 1;37(7):1477-1482.e1. doi: 10.1016/j.clinthera.2015.04.011. Epub 2015 May 27. PMID: 26024569
  22. DiMondi VP, Townsend ML, Drew RH. Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection. Int J Clin Pharm. 2015 Apr;37(2):348-54. doi: 10.1007/s11096-015-0067-6. Epub 2015 Jan 31. PMID: 25637406
  23. Hamilton KW, Gerber JS, Moehring RW, Anderson DJ, Calderwood MS, Han JH, Mehta JM, Pollack LA, Zaoutis T, Srinivasan A, Camins BC, Schwartz DN, Lautenbach E, for the CDC Prevention Epicenters Program.  Point-of-Prescription Interventions to Improve Antimicrobial Stewardship. Clin Infect Dis (2015) 60 (8): 1252-1258 DOI: 10.1093/cid/civ018
  24. Lewis SS, Walker VJ, Lee MS, Chen L, Moehring RW, Cox CE, Sexton DJ, Anderson DJ. Epidemiology of Methicillin-Resistant Staphylococcus aureus Pneumonia in Community Hospitals. Infect Control Hosp Epidemiol. 2014 Dec;35(12):1452-7. DOI: 10.1086/678594
  25. Thaden J, Lewis SS, Hazen KC, Huslage K, Fowler VG, Moehring RW, Chen LF, Jones CD, Moore ZS, Sexton DJ, Anderson DJ.  Rising Rates of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals: A Mixed-Methods Review of Epidemiology and Microbiology Practices in a Network of Community Hospitals in the Southeastern United States.  Infect Control Hosp Epidemiol 2014 Aug;35(8):978-83. DOI: 10.1086/677157
  26. Dodds Ashley ES, Kaye KS, DePestel DD, Hermsen ED. Antimicrobial stewardship: philosophy versus practice. Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S112-21. doi: 10.1093/cid/ciu546. PMID: 25261538
  27. Hoy Z, Dodds Ashley ES, Weinberg GA, Krysan DJ.Voriconazole Therapeutic Drug Monitoring. J Pediatric Infect Dis Soc. 2014 Sep;3(3):270-1. doi: 10.1093/jpids/piu019. Epub 2014 Mar 30. No abstract available. PMID: 26625392
  28. Lofgren E, Cole SR, Weber DJ, Anderson DJ, Moehring RW.  Estimating all-cause mortality and length of stay in incident, healthcare facility-associated Clostridium difficile cases using parametric mixture models.  Epidemiology 2014 Jul;25(4):570-5. DOI: 10.1097/EDE.0000000000000119
  29. Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014 Jul;34(7):670-6. doi: 10.1002/phar.1442. Epub 2014 May 22. PMID: 24855041
  30. Fridkin S, Baggs J, Fagan R, Magill S, Pollack LA, Malpiedi P, Slayton R, Khader K, Rubin MA, Jones M, Samore MH, Dumyati G, Dodds-Ashley E, Meek J, Yousey-Hindes K, Jernigan J, Shehab N, Herrera R, McDonald CL, Schneider A, Srinivasan A; Centers for Disease Control and Prevention (CDC). Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):194-200. PMID: 24598596
  31. Lofgren ET, Moehring RW, Anderson DJ, Weber DJ, Fefferman NH.  A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection.  Infect Control Hosp Epidemiol 2014; 35(1):18-27. DOI: 10.1086/674394
  32. Kung HC, Johnson MD, Drew RH, Saha-Chaudhuri P, Perfect JR. Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.
    Cancer Med. 2014 Jun;3(3):667-73. doi: 10.1002/cam4.225. Epub 2014 Mar 19. PMID: 24644249
  33. Chen LF,  Freeman JT, Nicholson B, Keiger A, Lancaster A, Joyce M, Woods CW, Cook E, Adcock L, Louis S, Cromer AL, Sexton DJ, Anderson DJ.  Widespread Dissemination of CTX-M 15 Genotype Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae among Patients Presenting to Community Hospitals in southeastern United States - Clinical and Molecular Epidemiology.  Antimicrob Agent Chemother 2014; 58(2):1200-2. DOI: 10.1128/AAC.01099-13
  34. Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich EN, Hall KK, Morgan DJ; Benefits of Universal Glove and Gown (BUGG) Investigators, Shahryar SK, Price CS, Gadbaw JJ, Drees M, Kett DH, Muñoz-Price LS, Jacob JT, Herwaldt LA, Sulis CA, Yokoe DS, Maragakis L, Lissauer ME, Zervos MJ, Warren DK, Carver RL, Anderson DJ, Calfee DP, Bowling JE, Safdar N.  Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.  JAMA. 2013 Oct 16;310(15):1571-80. DOI: 10.1001/jama.2013.277815
  35. Moehring RW, Sloane R, Chen LF, Smathers EC, Schmader KE, Fowler VG Jr, Weber DJ, Sexton DJ, Anderson DJ. Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study.  PLoS One. 2013 Oct 3;8(10):e76225. DOI: 10.1371/journal.pone.0076225
  36. Baker AW, Durkin MJ, Dicks KV, Lewis SS, Moehring RW, Chen LF, Sexton DJ, Anderson DJ. Methicillin-resistant Staphylococcus aureus bloodstream infection surveillance: national healthcare safety network's laboratory-identified event reporting versus traditional laboratory-confirmed bloodstream infection surveillance. Infect Control Hosp Epidemiol. 2014 Oct;35(10):1286-9. DOI: 10.1086/678071
  37. Dose ratios between high dose oral morphine or equivalents and oral methadone. Chatham MS, Dodds Ashley ES, Svengsouk JS, Juba KM. J Palliat Med. 2013 Aug;16(8):947-50. doi: 10.1089/jpm.2012.0434. Epub 2013 May 10. PMID: 23662952
  38. Johnson SW, Anderson DJ, May DB, Drew RH. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum beta-lactamase-producing enterobacteriaceae on hospital admission. Infect Control Hosp Epidemiol 2013;34(4):385-92. DOI: 10.1086/669858
  39. Sarraf-Yazdi S, Sharpe M, Bennett KM, Dotson TL, Anderson DJ, Vaslef SN. A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. J Surg Res 2012;176(2):e73-8. DOI: 10.1016/j.jss.2011.12.014
  40. Morgan DJ, Meddings J, Saint S, Lautenbach E, Shardell M, Anderson D, et al. Does Nonpayment for Hospital-acquired Catheter-Associated Urinary Tract Infections Lead to Over-Testing and Increased Antimicrobial Prescribing? Clin Infect Dis. 2012;55(7):923-9. DOI: 10.1093/cid/cis556
  41. Anderson DJ, Miller B, Marfatia R, Drew R. Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation. Infect Control Hosp Epidemiol. 2012;33(6):589-93. DOI: 10.1086/665721
  42. Dodds Ashley E, Drew R, Johnson M, Danna R, Dabrowski D, Walker V, Prasad M, Alexander B, Papadopoulos G, Perfect J. Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options.
    Pharmacotherapy. 2012 Oct;32(10):890-901. doi: 10.1002/j.1875-9114.2012.01124. PMID: 23033228
  43. Stevens V, Lodise TP, Tsuji B, Stringham M, Butterfield J, Dodds Ashley E, Brown K, Forrest A, Brown J. The utility of acute physiology and chronic health evaluation II scores for prediction of mortality among intensive care unit (ICU) and non-ICU patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2012 Jun;33(6):558-64. doi: 10.1086/665731. Epub 2012 Apr 13. PMID: 22561710
  44. Pitman SK, Drew RH, Perfect JR. Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations. Expert Opin Emerg Drugs. 2011 Sep;16(3):559-586. Epub 2011 Aug 17. DOI: 10.1517/14728214.2011.607811 PMID: 21846302
  45. DiMondi VP, Drew RH, Chen LF. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. Expert Rev Anti Infect Ther. 2011 Aug;9(8):567-72. doi: 10.1586/eri.11.82.
    PMID: 21819323
  46. Townsend ML, Pound MW, Drew RH. Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia. Infect Drug Resist. 2011;4:77-86. doi: 10.2147/IDR.S6030. Epub 2011 Mar 2. PMID: 21694911
  47. Alexander BD, Winkler TP, Shi S, Dodds Ashley ES, Hickey AJ. In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols. Pharm Dev Technol. 2011 Nov-Dec;16(6):577-82. doi: 10.3109/10837450.2011.591803. Epub 2011 Jun 23. PMID: 21699390
  48. Herzke CA, Chen LF, Anderson DJ, Choi Y, Sexton DJ, Kaye KS. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss. Infect Control Hosp Epidemiol. 2009;30(11):1057-61. DOI: 10.1086/606163
  49. Freeman JT, Sexton DJ, Anderson DJ. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States? Clin Infect Dis. 2009;49(2):e30-2. DOI: 10.1086/600046
  50. Anderson DJ, Kaye KS, Chen LF, Schmader KE, Choi Y, Sloane R, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS One. 2009;4(12):e8305. DOI:10.1371/journal.pone.0008305
  51. Smith WJ, Drew RH. Telavancin: a new lipoglycopeptide for gram-positive infections. Drugs Today (Barc). 2009 Mar;45(3):159-73. doi: 10.1358/dot.2009.45.3.1343792. Review. PMID: 19436839
  52. Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis. 2008;46(10):1568-77. DOI: 10.1086/587673
  53. Anderson DJ, Engemann JJ, Harrell LJ, Carmeli Y, Reller LB, Kaye KS. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2006;50(5):1715-20. DOI: 10.1128/AAC.50.5.1715-1720.2006
  54. McDonald JR, Engemann JJ, Kaye KS, Sexton DJ. Co-infection or co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a network of community hospitals. Infect Control Hosp Epidemiol. 2004;25(8):622. DOI: 10.1128/AAC.50.5.1715-1720.2006
  55. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36(5):592-8. DOI: 10.1086/367653


  1. Sexton DJ, Moehring RW. Implementation of antimicrobial stewardship programs in small community hospitals: Recognizing the barriers and meeting the challenge. Clin Infect Dis 2017 cix409. doi: 10.1093/cid/cix409
  2. Anderson DJ, Sexton DJ.  Surgical antimicrobial prophylaxis - is the glass half empty or more than 99% full?  Infect Control Hosp Epidemiol 2014 Mar;35(3):240-2. DOI: 10.1086/675290
  3. Sexton DJ, Miller BA, Anderson DJ. Measuring the effect of inappropriate initial antibiotic therapy on outcomes of patients with Gram-negative sepsis: An imprecise science. Crit Care Med. 2011;39(1):199-200. DOI: 10.1097/CCM.0b013e318202e68f
  4. Freeman J, Anderson D, Sexton DJ. Emerging evidence for seasonality of gram-negative bacterial infections. Infect Control Hosp Epidemiol. 2009;30(8):813-4. DOI: 10.1086/597506
  5. Varkey JB, Anderson DJ, Kaye KS. Preventing surgical site infections in the era of methicillin-resistant Staphylococcus aureus. Curr Infect Dis Rep. 2008;10(5):341-2. DOI: 10.1007/s11908-008-0054-3


  1. Chen LF, Anderson DJ. Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies. Future Microbiol 2012;7(6):677-83. DOI: 10.2217/fmb.12.44
  2. Hostler CJ, Chen LF. Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis. Expert Opin Pharmacother 2013. DOI: 10.1517/14656566.2013.802307
  3. Drew RH, Townsend ML, Pound MW, Johnson SW, Perfect JR. Recent advances in the treatment of life-threatening, invasive fungal infections.Expert Opin Pharmacother. 2013 Dec;14(17):2361-74. doi: 10.1517/14656566.2013.838217. Epub 2013 Sep 19. Review. PMID: 24050675
  4. Moehring RW, Anderson DJ. Antimicrobial stewardship as part of the infection prevention effort. Curr Infect Dis Rep 2012;14(6):592-600. DOI: 10.1007/s11908-012-0289-x
  5. Khadem TM, Dodds Ashley E, Wrobel MJ, Brown J. Antimicrobial stewardship: a matter of process or outcome? Pharmacotherapy. 2012 Aug;32(8):688-706. doi: 10.1002/j.1875-9114.2012.01154.x. Review. PMID: 23307518
  6. Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist 2012;5:133-41. DOI: 10.2147/IDR.S26613
  7. Wilson DT, Dimondi VP, Johnson SW, Jones TM, Drew RH. Role of isavuconazole in the treatment of invasive fungal infections. Ther Clin Risk Manag. 2016 Aug 3;12:1197-206. doi: 10.2147/TCRM.S90335. eCollection 2016. Review.
    PMID: 27536124
  8. Johnson SW, Drew RH, May DB. How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable? J Clin Pharm Ther. 2013 Apr;38(2):85-8. doi: 10.1111/jcpt.12034. Epub 2013 Jan 27. Review. PMID: 23350743
  9. Chen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Med Clin North Am. 2011;95(4):647-76, vii. DOI: 10.1016/j.mcna.2011.03.005
  10. Chen LF, Chastain C, Anderson DJ. Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention. Curr Infect Dis Rep. 2011;13(5):442-50. DOI: 10.1007/s11908-011-0198-4
  11. Anderson DJ. Surgical site infections. Infect Dis Clin North Am. 2011;25(1):135-53. DOI: 10.1016/j.idc.2010.11.004
  12. Holt SL, Drew RH.Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infections. Am J Health Syst Pharm. 2011 Jul 1;68(13):1207-20. doi: 10.2146/ajhp100456. Review. PMID: 21690427
  13. Bosso JA, Drew RH. Application of antimicrobial stewardship to optimise management of community acquired pneumonia. Int J Clin Pract. 2011 Jul;65(7):775-83. doi: 10.1111/j.1742-1241.2011.02704.x. Review. PMID: 21676120
  14. Pound MW, Townsend ML, Dimondi V, Wilson D, Drew RH. Overview of treatment options for invasive fungal infections. Med Mycol. 2011 Aug;49(6):561-80. doi: 10.3109/13693786.2011.560197. Epub 2011 Mar 3. Review.
    PMID: 21366509
  15. Dodds-Ashley E. Management of drug and food interactions with azole antifungal agents in transplant recipients. Pharmacotherapy. 2010 Aug;30(8):842-54. doi: 10.1592/phco.30.8.842. Review. PMID: 20653361
  16. Pound MW, Townsend ML, Drew RH. Echinocandin pharmacodynamics: review and clinical implications. J Antimicrob Chemother. 2010 Jun;65(6):1108-18. doi: 10.1093/jac/dkq081. Epub 2010 Mar 23. Review. PMID: 20335190
  17. Chen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Infect Dis Clin North Am. 2009;23(4):817-45, vii. DOI: 10.1016/j.idc.2009.06.002
  18. Anderson DJ, Kaye KS. Controlling antimicrobial resistance in the hospital. Infect Dis Clin North Am. 2009;23(4):847-64, vii-viii. DOI: 10.1016/j.idc.2009.06.005


  1. Baker AW, Chen LF. Letter to the editor regarding: "Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis" by Chiang et al. Spine J. 2014 Jun 1;14(6):1092. DOI: 10.1016/j.spinee.2014.01.061
  2. Lewis SS, Moehring RW, Anderson DJ, Sexton DJ, Chen LF. Increasing rates of methicillin-resistant Staphylococcus aureus in academic hospitals: a result of active surveillance? Infect Control Hosp Epidemiol 2013;34(1):105-6. DOI: 10.1086/668797
  3. Chen LF, Anderson DJ, Kaye KS, Sexton DJ. Methicillin-resistant Staphylococcus aureus in hospitals: time for a culture change. Med J Aust. 2008;188(1):62-3; author reply 3-4. PMID:18383601
  4. Anderson DJ, Kaye KS, Sexton DJ. Methicillin-resistant Staphylococcus aureus bacteremia after isolation from urine. Clin Infect Dis. 2006;42(10):1504-5. DOI: 10.1086/503679


page updated 3/2018